Zhejiang Yongtai Technology

Zhejiang Yongtai Technology is a leading Chinese CMO/CDMO specializing in fluorine chemicals and the manufacture of small molecule APIs/intermediates for pharmaceuticals. It operates globally with multiple manufacturing sites certified to US FDA/EU GMP standards. The company supplies both regulated markets and emerging markets with a broad portfolio of generic APIs such as carbidopa, duloxetine hydrochloride, gabapentin, celecoxib, esomeprazole magnesium among others. It also conducts clinical bioequivalence studies for its finished dosage forms but does not appear to have proprietary novel drug development programs or platforms.